1. Progress: Bangladesh CCM GF SEA Constituency Meeting New Delhi, India
Manaj Kumar Biswas
BCCM Coordinator
Date: April 2018

2. Progress: Tuberculosis
TB Indicator
Baseline Status in Year
Achievement in Year
Remarks
Prevalence rate/ pop.
505 (1990)
404 (2016)
Incidence rate / pop
205(1990)
221 (2016)
Case Notification rate/ pop
88 (2005)
149 (2017)
Number of MDR cases enrolled on treatment
236 (2008)
6,416 (2017)
Treatment success rate MDR TB% 9-month regimen
80% 2008)
75%
achieved a cure rate of 75%.
Treatment success rate new smear positive
85% (2003)
95% (2016)
(cure rate >90%)
TB Mortality rate / pop.
80(1990)
40 (50% reduced)

3. Global Strategy and targets for TB prevention, care ad control”
Vision: A WORLD FREE OF TB: Zero death, disease and suffering due to TB
GOAL: END THE GLOBAL TB EPIDEMIC
Indicators
Milestones
Targets
2020
2025
2030 (part of SDG)
End TB 2035
Reduction in number of TB deaths compared with 2015 (%)
35%
75%
90%
95%
Reduction in number of TB incidence compared with 2015 (%)
20%
50%
80%
<10 cases/100k
TB affected families facing catastrophic costs due to TB (%)
Zero

4. Progress :Malaria Country Situation in 2017 Total Cases – 29,247
Risk Population – million in 13 districts
Total Cases – 29,247
Pf – 80%, Pv – 15%, Mixed – 5%
Death – 13
API – 1.64 / 1,000 population
Mortality– 0.07/ 100,000 population
ABER – 5.54%
Test Positivity Rate – 2.96%
26% malaria case reduction since 2015
(29,247 in 2017 comparing to 39,719 in 2015)
44% malaria death increased since 2015
(13 in 2017 comparing to 9 in 2015)
66% less cases in 8 elimination districts since 2015

5. Malaria Trend in Bangladesh: 2007 - 2017

6. Species wise Malaria Cases: 2010 - 2017

7. > Than 90% of cases from CHT: 2010 - 2017
Malaria burden in CHT: January - December'
DISTRICTS
(Jan-Dec 2010)
(Jan-Dec 2011)
(Jan-Dec 2012)
(Jan-Dec 2013)
(Jan-Dec 2014)
(Jan-Dec 2015)
(Jan-Dec 2016)
(Jan-Dec 2017)
Case
Death
Khagrachari
22%
35%
25%
42%
20%
55%
15%
47%
17%
24%
10% 0% 7% 5%
Rangamati
27%
26%
14% 9%
30%
13%
28%
Bandarban
31%
19%
33%
29%
46%
44%
51%
60%
23%
Total
78%
81%
83%
89%
76%
91%
80%
90%
58%
93%
53%

8. Malaria Elimination Goal
Malaria free Bangladesh by 2030
This goal set up in current HPNSDP

9. Progress : HIV / AIDS
Bangladesh maintaining very low prevalence and incidence of HIV and AIDS since long time. Less than 1% in Key Affected Population and less than 0.1% in total population.
Recent sero surveillance report shows increase of prevalence in IDU in some areas of Dhaka city

10. Total GF Grants in Bangladesh (2003-2016) (U$$)
Component
Signed
Committed
Disbursed
HIV/AIDS
US$140,014,877
US$128,518,466
US$121,182,992
Tuberculosis
US$363,613,092
US$302,331,005
US$256,383,009
Malaria
US$114,837,852
US$96,004,397
US$88,812,638
Total
US$618,465,821
US$526,853,867
US$466,378,639

11. Challenges
Donor funding is gradually reducing including GF for TB,Malaria and HIV
MDR TB increasing and remains under diagnosis case of MDR TB
Child TB identification is not up to the mark
Still left out about 30% of TB cases out of identification
Private sector involvement in fighting three diseases
Surveillance gap in the area of non endemic areas of Malaria
Sustainability challenges for TB, malaria and HIV
No transition plan take place yet for Government

12. Bangladesh CCM
The Bangladesh Country Coordinating Mechanism (BCCM) was established in July 2002 in response to the requirements of the Global Fund (GFATM). BCCM Reconstitution: BCCM usually reconstitutes itself every three years. BCCM has completed its reconstitution according to its Governance manual and the GF’s CCM guidelines in 2017.

13. BCCM Structure Total 41 members (including PRs & Observer)
Total voting Members 33 and alternate 33, Among them
GOV ( Selected by Govt. from different ministries)
ML/BL ( Elected by Constituency)
PLWD(HIV,TB,Mal) 3 ( Elected by Constituency)
KAP 3 ( Elected by Constituency)
NGOs 4 ( Elected by Constituency)
FBO (Elected by Constituency)
Academia 2 ( Elected by Constituency)
Private Sector 2 ( Elected by Constituency)
 ____________________________________________________________________________________________________________________________
Observers (Non Voting): Challenge TB 1 (Selected)
LFA 2 (Selected)
PR Representatives (Non Voting):
NTP, NMCP, NASP (Selected)
BRAC, Icddr,b, SC
Total members (including PRs & Observer)

14. BCCM Committees
Executive Committee: BCCM has authorized its Executive Committee again in The Executive committee is comprised of Chair Vice Chair of BCCM and Chair Vice Chair of Oversight Committee and BCCM Coordinator (Non voting).
BCCM re-established and endorsed the Oversight Committee of BCCM in January 2017, which is comprised of 19 from including disease expert (HIV, TB, Malaria), PSM expert, Finance expert, KAP private sector, MLBL, Government and B CCM Coordinator (non –voting)

15. Technical Working Group for TB, Malaria and HIV
BCCM has three Technical Working Group which are popularly known as Technical Sub Committee. These committee reformed in 2017 which are as follows:
TB Technical Working Group (TB-TWG)
Malaria Technical Working Group(Malaria-TWG)
HIV Technical Working Group (HIV -TWG)

16. BCCM Secretariat BCCM Coordinator Deputy Coordinator
BCCM secretariat situated in the Ministry of Health and Family Welfare Bangladesh.
BCCM Secretariat also redesigned by the Global Fund and Bangladesh CCM. Previously there were three staffs. But now only two positions since January 2017:
Two positions are there as follows:
BCCM Coordinator
Deputy Coordinator

17. Principal Recipients
Bangladesh CCM has six Principal recipients for three diseases which all are rated A and A+ in regard their performance. These PRs are as follows: All
Name of PRs
Disease component
Govt/ Non-Got
National TB Control Programme (NTP) (A) TB
Government
National Malaria Control Programme (NMCP) (A+)
Malaria
National STD and AIDS Programme (NASP)
HIV/AIDS
Bangladesh Rural Advancement Committee (BRAC) (A+)
TB & Malaria
Non-Government
International Diarrhoeal Diseases and Research in Bangladesh (icddr,b) A+
Save the Children International (SCI) A+

18. BCCM Functions: Funding Agreement 2018-2020
GF Board approved funding request under NFR in October 2017
Framework Agreement and Grant confirmation signing completed in November 2017
Grant Disbursement for all components have started in January 2018
Grants Implementation and Oversight also started

19. Thanks